Theradiag (France) Executives
| ALTHE Stock | EUR 0.26 0.01 3.70% |
Theradiag employs about 28 people. The company is managed by 7 executives with a total tenure of roughly 66 years, averaging almost 9.0 years of service per executive, having 4.0 employees per reported executive. Discussion of Theradiag's management performance can provide insight into the enterprise performance.
| Yann Duchesne Insider Ex Chairman |
| Roberta Brocardo Insider Ex Officer |
Theradiag |
Theradiag Management Team Effectiveness
The company has return on total asset (ROA) of (0.2533) % which means that it has lost $0.2533 on every $100 spent on assets. This is way below average. Theradiag's management efficiency ratios could be used to measure how well Theradiag manages its routine affairs as well as how well it operates its assets and liabilities.Theradiag Workforce Comparison
Theradiag SA is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 252. Theradiag retains roughly 28.0 in number of employees claiming about 11% of equities under Health Care industry.
Theradiag SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Theradiag SA Price Series Summation is a cross summation of Theradiag price series and its benchmark/peer.
Theradiag Notable Stakeholders
A Theradiag stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Theradiag often face trade-offs trying to please all of them. Theradiag's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Theradiag's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Yann Duchesne | Ex Chairman | Profile | |
| Roberta Brocardo | Ex Officer | Profile | |
| Jose AbellanMartinez | VP Devel | Profile | |
| Anja Kleber | VP Access | Profile | |
| David Auregan | Chief Officer | Profile | |
| Gaylord Tallec | Director Operations | Profile | |
| Michel MD | VP Officer | Profile |
About Theradiag Management Performance
The success or failure of an entity such as Theradiag SA often depends on how effective the management is. Theradiag management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Theradiag management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Theradiag management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Theraclion SA develops, manufactures, and markets Echopulse ultrasound medical imaging tool for the non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules to practitioners. The company was founded in 2004 and is based in Malakoff, France. THERACLION operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 22 people.
Theradiag Workforce Analysis
Traditionally, organizations such as Theradiag use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Theradiag within its industry.Theradiag Manpower Efficiency
Return on Theradiag Manpower
| Revenue Per Employee | 52.9K | |
| Revenue Per Executive | 211.6K | |
| Net Loss Per Employee | 134.3K | |
| Net Loss Per Executive | 537.2K |
Additional Tools for Theradiag Stock Analysis
When running Theradiag's price analysis, check to measure Theradiag's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theradiag is operating at the current time. Most of Theradiag's value examination focuses on studying past and present price action to predict the probability of Theradiag's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theradiag's price. Additionally, you may evaluate how the addition of Theradiag to your portfolios can decrease your overall portfolio volatility.